Barclays PLC Decreases Stock Position in The Clorox Company (NYSE:CLX)

Barclays PLC cut its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 47.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 651,297 shares of the company's stock after selling 590,825 shares during the quarter. Barclays PLC owned approximately 0.53% of Clorox worth $106,102,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Catalyst Capital Advisors LLC purchased a new stake in Clorox during the third quarter valued at about $54,000. Raymond James & Associates boosted its holdings in Clorox by 32.8% during the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company's stock valued at $36,524,000 after acquiring an additional 66,149 shares during the period. M&G Plc bought a new position in Clorox during the 2nd quarter worth approximately $876,000. AQR Capital Management LLC increased its stake in Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company's stock worth $39,121,000 after purchasing an additional 22,676 shares during the period. Finally, Assenagon Asset Management S.A. lifted its position in Clorox by 371.4% in the second quarter. Assenagon Asset Management S.A. now owns 96,969 shares of the company's stock valued at $13,233,000 after purchasing an additional 76,397 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 0.0 %

NYSE CLX traded up $0.02 during trading hours on Thursday, reaching $164.68. 1,028,309 shares of the company's stock traded hands, compared to its average volume of 1,231,568. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a 50-day simple moving average of $163.63 and a 200 day simple moving average of $151.21. The firm has a market cap of $20.38 billion, a PE ratio of 57.35, a PEG ratio of 3.08 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business's revenue was up 27.0% on a year-over-year basis. During the same period last year, the business earned $0.49 earnings per share. Sell-side analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. Clorox's dividend payout ratio is currently 170.03%.

Analysts Set New Price Targets

CLX has been the topic of several analyst reports. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research note on Friday, October 11th. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a report on Monday, October 14th. BNP Paribas upgraded Clorox to a "strong sell" rating in a report on Friday, September 6th. Citigroup increased their price objective on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Finally, DA Davidson boosted their target price on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.